• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 234-248 of 300 results

1046 Exhibit: Brentjens

Document IPR2022-00855, No. 1046 Exhibit - Brentjens (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

1009 Exhibit: Littman

Document IPR2022-00855, No. 1009 Exhibit - Littman (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

2074 Exhibit: EX 2074

Document IPR2022-00855, No. 2074 Exhibit - EX 2074 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze

2066 Exhibit: EX 2066

Document IPR2022-00855, No. 2066 Exhibit - EX 2066 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze

2032 Exhibit: Michael C Jensen et al, Antitransgene Rejection Responses Contribu...

Document IPR2022-00855, No. 2032 Exhibit - Michael C Jensen et al, Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20CD19 Specific Chimeric Anti...

cite Cite Document
Analyze

2080 Exhibit: EX 2080

Document IPR2022-00855, No. 2080 Exhibit - EX 2080 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze

2070 Exhibit: EX 2070

Document IPR2022-00855, No. 2070 Exhibit - EX 2070 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze

1033 Exhibit: Huston

Document IPR2022-00855, No. 1033 Exhibit - Huston (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

1035 Exhibit: McDowell

Document IPR2022-00855, No. 1035 Exhibit - McDowell (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

2011 Exhibit: Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin ly...

Document IPR2022-00855, No. 2011 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 specific ...

cite Cite Document
Analyze

2012 Exhibit: Renier J Brentjens et al, Safety and persistence of adoptively transfe...

Document IPR2022-00855, No. 2012 Exhibit - Renier J Brentjens et al, Safety and persistence of adoptively transferred autologous CD19 targeted T cells in patients with relapsed or chemotherapy refracto...

cite Cite Document
Analyze

2031 Exhibit: Steven A Rosenberg et al, Use of Tumor Infiltrating Lymphocytes and...

Document IPR2022-00855, No. 2031 Exhibit - Steven A Rosenberg et al, Use of Tumor Infiltrating Lymphocytes and Interleukin 2 in the Immunotherapy of Patients with Metastatic Melanoma, 319 NEW ENG...

cite Cite Document
Analyze

2016 Exhibit: Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Imm...

Document IPR2022-00855, No. 2016 Exhibit - Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Immunotherapy, 342 SCI 1432 2013 (P.T.A.B. Jul. 19, 2022)

cite Cite Document
Analyze

2045 Exhibit: SITC Smalley Award 2013 Recipient, SOC���Y FOR IMMUNOTHERAP...

Document IPR2022-00855, No. 2045 Exhibit - SITC Smalley Award 2013 Recipient, SOC���Y FOR IMMUNOTHERAPY OF CANCER, httpswwwsitcancerorgfundingnamed funds and awards2smalley2013 las...

cite Cite Document
Analyze

1025 Exhibit: Turco

Document IPR2022-00855, No. 1025 Exhibit - Turco (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 16 17 18 19 20 ... >>